Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

cisplatin

  • Open Access
    The Mechanism of the Synergistic Anticancer Effect of CDDP and EPA in the TE1 Cell Line
    AYAKO OGO, SACHI MIYAKE, HISAKO KUBOTA, MASAHARU HIGASHIDA, HIDEO MATSUMOTO, FUSAKO TERAMOTO, TOSHIHIRO HIRAI and TOMIO UENO
    Anticancer Research April 2021, 41 (4) 1771-1778; DOI: https://doi.org/10.21873/anticanres.14942
  • Open Access
    Modified TPEx as First-line Treatment for Recurrent and/or Metastatic Head and Neck Cancer
    MOTOYUKI SUZUKI, YUKINORI TAKENAKA, TOSHIHIRO KISHIKAWA, YOSHIFUMI YAMAMOTO, ATSUSHI HANAMOTO, YOICHIRO TOMIYAMA, TAKAHITO FUKUSUMI, TAKAHIRO MICHIBA, NORIHIKO TAKEMOTO, SUSUMU NAKAHARA and HIDENORI INOHARA
    Anticancer Research April 2021, 41 (4) 2045-2051; DOI: https://doi.org/10.21873/anticanres.14973
  • You have access
    Acute Kidney Injury Following Hyperthermic Intraperitoneal Chemotherapy With Cisplatin
    KERRY L. CHEN, RAPHAEL SHAMAVONIAN, JOSH B. KARPES, NAYEF A. ALZAHRANI and DAVID L. MORRIS
    Anticancer Research March 2021, 41 (3) 1641-1646; DOI: https://doi.org/10.21873/anticanres.14926
  • You have access
    Anticancer Efficacy and Mechanism of Amentoflavone for Sensitizing Oral Squamous Cell Carcinoma to Cisplatin
    CHENG-HSIEN CHEN, YI-CHI HUANG, YUAN-HAO LEE, ZHAO-LIN TAN, CHIA-JUNG TSAI, YAO-CHEN CHUANG, HSI-FENG TU, TA-CHIH LIU and FEI-TING HSU
    Anticancer Research December 2020, 40 (12) 6723-6732; DOI: https://doi.org/10.21873/anticanres.14695
  • You have access
    Protein Profiling of Extracellular Vesicles Associated With Cisplatin Resistance in Lung Cancer
    HELIER BALBINOTTI, NATHAN A. CADORE, CRISTINE S. DUTRA, EDILEUZA D. DA SILVA, HENRIQUE B. FERREIRA, ARNALDO ZAHA and KARINA M. MONTEIRO
    Anticancer Research October 2020, 40 (10) 5509-5516; DOI: https://doi.org/10.21873/anticanres.14563
  • You have access
    High Expression of p21 as a Potential Therapeutic Target in Ovarian Clear-cell Carcinoma
    YUKI MINAGAWA, KOUSUKE ISHINO, RYUICHI WADA, MITSUHIRO KUDO, ZENYA NAITO, TOSHIYUKI TAKESHITA and RYUJI OHASHI
    Anticancer Research October 2020, 40 (10) 5631-5639; DOI: https://doi.org/10.21873/anticanres.14576
  • You have access
    Safety and Efficacy of Gemcitabine, Docetaxel, Capecitabine, Cisplatin as Second-line Therapy for Advanced Pancreatic Cancer After FOLFIRINOX
    JEAN-DAVID FUMET, JULIE VINCENT, LEILA BENGRINE, AUDREY HENNEQUIN, LAURA GRANCONATO, REMI PALMIER and FRANÇOIS GHIRINGHELLI
    Anticancer Research July 2020, 40 (7) 4011-4015; DOI: https://doi.org/10.21873/anticanres.14395
  • You have access
    Characteristics of Gastric Carcinomas With High ERCC1 Expression and the Prognostic Value of ERCC1 Expression
    JUNG WOOK YANG, JEONG-HEE LEE, JONG SIL LEE, DONG CHUL KIM, DAE HYUN SONG, SE MIN JANG, HYO JUNG AN, HYUN MIN KOH, MINHYE KIM, JI MIN NA, SANG-HO JEONG, YOUNG-JOON LEE and GYUNG HYUCK KO
    Anticancer Research June 2020, 40 (6) 3203-3208; DOI: https://doi.org/10.21873/anticanres.14301
  • You have access
    Clinical Significance of Jagged-1 Activated by APEX1 as a Chemoresistance Factor in Advanced Gastric Cancer
    HONG-BEUM KIM, HEE-JEONG LEE, GEE-BEUM KIM, HYUN-JONG LIM, JUN HEE PARK and SANG-GON PARK
    Anticancer Research April 2020, 40 (4) 1897-1904; DOI: https://doi.org/10.21873/anticanres.14144
  • You have access
    Cigarette Smoke Reduces the Efficacy of Cisplatin in Head and Neck Cancer Cells – Role of ABCG2
    FLORIAN SIMON, SABINA SCHWENK-ZIEGER, SVEN BECKER, KRISTIAN UNGER, OLIVIER GIRES and PHILIPP BAUMEISTER
    Anticancer Research March 2020, 40 (3) 1277-1284; DOI: https://doi.org/10.21873/anticanres.14069

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 13
Anticancer Research

© 2021 Anticancer Research

Powered by HighWire